• Products
  • Community
  • Markets
  • Brokers
  • More
Get started
  • Ideas
  • /Clarustherapeutics

Clarustherapeutics

CRXT Clarus Therapeutics Bullish ReversalCRXT Clarus Therapeutics had 3 green days after its sell-off to all time low. This should signal a reversal pattern. Clarus Therapeutics has the first FDA-approved oral softgel for testosterone replacement therapy in adult males who have deficient testosterone due to certain medical conditions called JATENZO. The fist target is the $1.1 private placement offering price and then the $2.10 resistance. Few months ago they had another private placement at $4.96 per unit, so we can take that into c
CLong
by TopgOptions
CRXT 900% Upside Potential According to this analyst Clarus Therapeutics Holdings, Inc. (CRXT) Announced Initiation of Phase 4 Clinical Trial of JATENZO, the first and only FDA-approved oral softgel for testosterone replacement therapy in adult male. On 3/31/2022 Serge Belanger from Needham & Company LLC brokerage set a Buy Rating for CRXT and a Price Target of $8.00, which is 9 times higher than the current price. I think it can easily double. Looking forward to read your opinion about it.
CLong
by TopgOptions

Made by humans

Select market data provided by ICE Data Services. Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc.Copyright © 2026, American Bankers Association. CUSIP Database provided by FactSet Research Systems Inc. All rights reserved. SEC filings and other documents provided by Quartr.© 2026 TradingView, Inc.

SOC 2 CompliantGDPR Compliant
More than a product
  • Supercharts
Screeners
  • Stocks
  • ETFs
  • Bonds
  • Crypto coins
  • CEX pairs
  • DEX pairs
  • Pine
Heatmaps
  • Stocks
  • ETFs
  • Crypto coins
Calendars
  • Economic
  • Earnings
  • Dividends
  • IPOs
More products
  • News Flow
  • Portfolios
  • Fundamental Graphs
  • Yield Curves
  • Options
  • Macro Maps
  • Pine Script®
  • MCP Server
Apps
  • Mobile
  • Desktop
Community
  • Social network
  • Wall of Love
  • Refer a friend
  • Creator program
  • House Rules
  • Moderators
Ideas
  • Trading
  • Education
  • Editors' picks
Pine Script
  • Indicators & strategies
  • Wizards
  • Freelancers
  • Marketplace
Tools & subscriptions
  • Features
  • Pricing
  • Market data
  • Gift plans
Trading
  • Overview
  • Brokers
  • Brokers comparison
  • The Leap
Special offers
  • CME Group futures
  • Eurex futures
  • US stocks bundle
About company
  • Who we are
  • Space mission
  • Blog
  • Help Center
  • Careers
  • Media kit
Merch
  • Tarot cards for traders
  • The C63 TradeTime
Policies & security
  • Terms of Use
  • Disclaimer
  • Privacy Policy
  • Cookies Policy
  • Accessibility Statement
  • Trust Center
  • Security tips
  • Bug Bounty program
  • Status page
Business solutions
  • Widgets
  • Charting libraries
  • Lightweight Charts™
  • Advanced Charts
  • Trading Platform
Growth opportunities
  • Advertising
  • Brokerage integration
  • Partner program
  • Education program
Community
  • Social network
  • Wall of Love
  • Refer a friend
  • Creator program
  • House Rules
  • Moderators
Ideas
  • Trading
  • Education
  • Editors' picks
Pine Script
  • Indicators & strategies
  • Wizards
  • Freelancers
  • Marketplace
Business solutions
  • Widgets
  • Charting libraries
  • Lightweight Charts™
  • Advanced Charts
  • Trading Platform
Growth opportunities
  • Advertising
  • Brokerage integration
  • Partner program
  • Education program
Look FirstLook First